The mathematical models of serum HE4 and CA125 combined application to improve the pelvic tumor differential diagnosis rate
نویسندگان
چکیده
OBJECTIVE: The objective of this study was to explore the combined usage of human epididymis protein 4 (HE4) and CA 125 to help the diagnosis and differentiating malignant pelvic masses from benign diseases. METHOD: This was a multicenter clinical study and nine hospitals had been involved and totally 779 patients with pelvic mass have been enrolled. The pathologic diagnosis confirmed that 288 patients suffered EOC. Serum levels of HE4 and CA125 were measured. RESULTS: The distributions of HE4 and CA125 have been analyzed and the ROMA score have been calculated. Then three new calculation formulas have been compared and the best one have been used to evaluate its clinical significance. The specificity of this diagnosis model ( ) to prediction the risk of cancer and staging have reached over 75%. CONCLUSION: The application of mathematical model in combined analysis multiple biomarkers could improve the clinical significance and proved more accurate laboratory information for clinical doctors. Proceedings IWBBIO 2014. Granada 7-9 April, 2014 109
منابع مشابه
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
BACKGROUND Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy. METHODS We retrospectively analyzed preoperative sera of 109 healthy women, 285 patients with benign ovarian masses (cystadenoma: n=78, leimyoma: n=66, endometriosis: n=52, ...
متن کاملبررسی ارزش تشخیصی CA125 و HE4 در مرحلهبندی کانسر آندومتر
Background: Endometrial carcinoma is considered the most common gynecological cancer in the world. Pelvic and para-aortic lymphadenectomy is widely advised based on FIGO staging system. The purpose of this study was to determine whether the biomarker human epididymis protein 4(HE4) correlates with depth of myometrial invasion, histologic grade and metastases in patients with endometrioid adenoc...
متن کاملSignificance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
BACKGROUND Human epididymis protein 4 (HE4) is a novel and specific biomarker for ovarian cancer. The aim of this study is to evaluate a new tumor marker, HE4, in comparison with CA125 in diagnosis of epithelial ovarian cancer (EOC) and benign gynecological diseases. METHODS CA125 and HE4 serum levels were determined in 30 patients with epithelial ovarian cancer (21 serous, 6 endometrioid and...
متن کاملValue of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer
OBJECTIVE To investigate the clinical significance of human epididymal secretory protein E4 (HE4) in combination with cancer antigen 125 (CA125) in the diagnosis of endometrial cancer. METHODS One hundred and fifty patients with endometrial cancer who were admitted to Binzhou People's Hospital, Shandong, China, between June 2013 and July 2014, were enrolled and set as an endometrial cancer gr...
متن کاملCorrelation of Preoperative HE-4 and CA125 with Ovarian Cancer Staging in Ahvaz Imam Khomeni Hospital
Background: Given that ovarian cancer symptoms are nonspecific and that appropriate surgical staging and pathological grading are important for the best treatment and prognosis of patients, this study aimed to determine the correlation of preoperative serum levels of CA125 and He4 with staging and grading. Materials and Methods: This cross-sectional study recruited 29 patients with epithelial...
متن کامل